Eileen P Ahearn

Summary

Country: USA

Publications

  1. ncbi Investigation of Notch3 as a candidate gene for bipolar disorder using brain hyperintensities as an endophenotype
    Eileen P Ahearn
    Department of Psychiatry, Duke University Medical Center, Durham, North Carolina, USA
    Am J Med Genet 114:652-8. 2002
  2. ncbi Pharmacologic treatment of posttraumatic stress disorder: a focus on antipsychotic use
    Eileen P Ahearn
    William S Middleton Memorial Veterans Hospital, Madison, Wisconsin 53705 2286, USA
    Ann Clin Psychiatry 15:193-201. 2003
  3. ncbi Quetiapine as an adjunctive treatment for post-traumatic stress disorder: an 8-week open-label study
    Eileen P Ahearn
    William S Middleton Memorial Veterans Hospital, University of Wisconsin, Madison, Wisconsin 53705, USA
    Int Clin Psychopharmacol 21:29-33. 2006
  4. ncbi A review of atypical antipsychotic medications for posttraumatic stress disorder
    Eileen P Ahearn
    William S Middleton Memorial Veterans Hospital, University of Wisconsin, Madison, USA
    Int Clin Psychopharmacol 26:193-200. 2011
  5. ncbi Suicide attempts in veterans with bipolar disorder during treatment with lithium, divalproex, and atypical antipsychotics
    Eileen P Ahearn
    William S Middleton Memorial Veterans Hospital, Madison, WI 53705 2286, United States
    J Affect Disord 145:77-82. 2013
  6. ncbi Fear, anxiety, and the neuroimaging of PTSD
    Eileen P Ahearn
    Willam S Middleton Memorial Veterans Hospital, Madison, WI, USA
    Psychopharmacol Bull 40:88-103. 2007
  7. ncbi Symptom profile consistency in recurrent manic episodes
    Frederick Cassidy
    Duke-Umstead Bipolar Disorder Program, Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA
    Compr Psychiatry 43:179-81. 2002
  8. ncbi Atypical antipsychotics, improved intrusive symptoms in patients with posttraumatic stress disorder
    Eileen P Ahearn
    Mil Med 168:x-xi. 2003
  9. ncbi Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial
    Dennis A Revicki
    Center for Health Outcomes Research, MEDTAP International, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    J Affect Disord 86:183-93. 2005
  10. ncbi Exacerbation of PTSD symptoms with use of duloxetine
    Michele L Deneys
    J Clin Psychiatry 67:496-7. 2006

Detail Information

Publications10

  1. ncbi Investigation of Notch3 as a candidate gene for bipolar disorder using brain hyperintensities as an endophenotype
    Eileen P Ahearn
    Department of Psychiatry, Duke University Medical Center, Durham, North Carolina, USA
    Am J Med Genet 114:652-8. 2002
    ..Multipoint linkage analysis yielded negative results except for Model 1a, in which a maximal LOD score was -1.24. A mutation screen of Exons 3 and 4 was negative. Notch3 does not appear to be a candidate gene for BPD in this family...
  2. ncbi Pharmacologic treatment of posttraumatic stress disorder: a focus on antipsychotic use
    Eileen P Ahearn
    William S Middleton Memorial Veterans Hospital, Madison, Wisconsin 53705 2286, USA
    Ann Clin Psychiatry 15:193-201. 2003
    ..The paucity of double-blind studies prevents firm conclusions, however, this class of medications may be useful particularly for refractory symptoms...
  3. ncbi Quetiapine as an adjunctive treatment for post-traumatic stress disorder: an 8-week open-label study
    Eileen P Ahearn
    William S Middleton Memorial Veterans Hospital, University of Wisconsin, Madison, Wisconsin 53705, USA
    Int Clin Psychopharmacol 21:29-33. 2006
    ..Subjects with PTSD who had significant PTSD symptoms when on an SSRI benefited from the addition of quetiapine. Patients improved significantly on all three clusters of PTSD symptoms: re-experiencing, hyperarousal and avoidance...
  4. ncbi A review of atypical antipsychotic medications for posttraumatic stress disorder
    Eileen P Ahearn
    William S Middleton Memorial Veterans Hospital, University of Wisconsin, Madison, USA
    Int Clin Psychopharmacol 26:193-200. 2011
    ..Larger randomized controlled trials are needed to clarify the potential utility of these medications in the treatment of PTSD and more rigorous examination of metabolic side effects is warranted...
  5. ncbi Suicide attempts in veterans with bipolar disorder during treatment with lithium, divalproex, and atypical antipsychotics
    Eileen P Ahearn
    William S Middleton Memorial Veterans Hospital, Madison, WI 53705 2286, United States
    J Affect Disord 145:77-82. 2013
    ..In this study, lithium and divalproex provided protection against suicide attempts. Results need to be replicated in future prospective studies and clearly strategies for improving medication compliance among veterans are warranted...
  6. ncbi Fear, anxiety, and the neuroimaging of PTSD
    Eileen P Ahearn
    Willam S Middleton Memorial Veterans Hospital, Madison, WI, USA
    Psychopharmacol Bull 40:88-103. 2007
    ....
  7. ncbi Symptom profile consistency in recurrent manic episodes
    Frederick Cassidy
    Duke-Umstead Bipolar Disorder Program, Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC, USA
    Compr Psychiatry 43:179-81. 2002
    ..e., mixed v pure manic episodes)...
  8. ncbi Atypical antipsychotics, improved intrusive symptoms in patients with posttraumatic stress disorder
    Eileen P Ahearn
    Mil Med 168:x-xi. 2003
  9. ncbi Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial
    Dennis A Revicki
    Center for Health Outcomes Research, MEDTAP International, 7101 Wisconsin Avenue, Suite 600, Bethesda, MD 20814, USA
    J Affect Disord 86:183-93. 2005
    ..The clinical, quality of life (QOL), and medical cost outcomes of treatment with divalproex were compared with lithium in patients with bipolar I disorder over 1 year...
  10. ncbi Exacerbation of PTSD symptoms with use of duloxetine
    Michele L Deneys
    J Clin Psychiatry 67:496-7. 2006